Corsevin M

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCorsevin M

Drug Alias NameFactor VIIa inhibitormouse antibody-based Factor VIIa inhibitorCorsevin M12D-10Fab

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment > Fab fragmentBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody murine

Mechanisms of ActionFactor VIIa inhibitors

TargetsCoagulation factor VII

Therapy Area/IndicationsDisseminated Intravascular CoagulationThromboembolismAngina, Unstable

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesDendreon Corp

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesCentocor Dendreon Corp

Active IndicationsN/A

Inactive IndicationsDisseminated Intravascular CoagulationThromboembolismAngina, Unstable

Other Information

ATC CodeN/A